Pancreatic Cancer Research

ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years

Nigel Mackman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9170-7700; OpenAlex author ID A5075629445; NIH RePORTER profile ID 1881373. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 2)
Trials
0
Grants
2
Labs led
1
Collaborators
36
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 grant · 2021: 4 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 grant

Papers 10

  1. Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic Cancer. Last author DOI 10.1055/s-0043-1761419↗
  2. Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer: Comment by Mackman et al. Co-author DOI 10.1111/cas.15276↗
  3. Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreatic cancer patients. Co-author DOI 10.1016/j.thromres.2020.12.018↗
  4. Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment. Co-author DOI 10.1111/jth.15115↗
  5. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer. Co-author DOI 10.1161/atvbaha.121.316463↗
  6. Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer. Co-author DOI 10.1182/bloodadvances.2020003149↗
  7. Distinct Pathogenesis of Pancreatic Cancer Microvesicle-Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo. Co-author DOI 10.1161/atvbaha.117.310262↗
  8. Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.7955↗
  9. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features. Co-author DOI 10.1111/eci.12042↗
  10. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Last author DOI 10.1182/blood-2012-01-402156↗

Grants 2

  1. Tissue factor-dependent coagulation in thrombosis and immune responses R35HL155657↗
  2. mechanism of venous thrombosis in pancreatic cancer R01HL147149↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yohei Hisada · 4 shared papers, 2021–2023 · strength 0.72
  2. Tomohiro Kawano · 2 shared papers, 2021–2023 · strength 0.32
  3. Ingrid Pabinger · 3 shared papers, 2013–2021 · strength 0.28
  4. Cihan Ay · 3 shared papers, 2013–2021 · strength 0.28
  5. Sierra J. Archibald · 1 shared paper, 2022 · strength 0.26
  6. Florian Moik · 2 shared papers, 2021 · strength 0.25
  7. Matthew J. Flick · 2 shared papers, 2021 · strength 0.24
  8. J. Thaler · 2 shared papers, 2013–2021 · strength 0.16
  9. Riitta Lassila · 1 shared paper, 2021 · strength 0.13
  10. Hanna E. Seppänen · 1 shared paper, 2021 · strength 0.13
  11. Caj H. Haglund · 1 shared paper, 2021 · strength 0.13
  12. Nora Mattila · 1 shared paper, 2021 · strength 0.13
  13. Gerald W. Prager · 1 shared paper, 2021 · strength 0.13
  14. Patrick G. Schweickert · 1 shared paper, 2021 · strength 0.12
  15. Yi Yang · 1 shared paper, 2021 · strength 0.12
  16. Emily White · 1 shared paper, 2021 · strength 0.12
  17. Stephen F Konieczny · 1 shared paper, 2021 · strength 0.12
  18. Alisa S. Wolberg · 2 shared papers, 2012–2016 · strength 0.07
  19. Vladimir Y. Bogdanov · 2 shared papers, 2012–2016 · strength 0.07
  20. Sonja M. Wörmann · 1 shared paper, 2018 · strength 0.06
  21. Steffen Maßberg · 1 shared paper, 2018 · strength 0.06
  22. Konstantin Stark · 1 shared paper, 2018 · strength 0.06
  23. Hana Algül · 1 shared paper, 2018 · strength 0.06
  24. Christiane J. Bruns · 1 shared paper, 2018 · strength 0.06
  25. Xiaoyang Qi · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.